Page last updated: 2024-10-23

azathioprine and Acantholytic Dyskeratotic Epidermal Nevi

azathioprine has been researched along with Acantholytic Dyskeratotic Epidermal Nevi in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levy, SL1
Salvi, SM1
Anolik, MA1
Rudolph, RI1

Other Studies

2 other studies available for azathioprine and Acantholytic Dyskeratotic Epidermal Nevi

ArticleYear
Reactivation of Darier's disease following Azathioprine treatment for thyroid eye disease.
    Eye (London, England), 2013, Volume: 27, Issue:4

    Topics: Azathioprine; Darier Disease; Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Middl

2013
Scabies simulating Darier disease in an immunosuppressed host.
    Archives of dermatology, 1976, Volume: 112, Issue:1

    Topics: Adult; Azathioprine; Darier Disease; Diagnosis, Differential; Female; Humans; Immunosuppression Ther

1976